Literature DB >> 31186862

Histological assessment of nonalcoholic fatty liver disease in adults and children.

Elizabeth M Brunt1.   

Abstract

Entities:  

Year:  2012        PMID： 31186862      PMCID： PMC6499275          DOI： 10.1002/cld.31

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  12 in total

Review 1.  Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond.

Authors:  E M Brunt
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

2.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

4.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

5.  NASH and cryptogenic cirrhosis: a histological analysis.

Authors:  Stephen H Caldwell; Vanessa D Lee; David E Kleiner; Abdullah M S Al-Osaimi; Curtis K Argo; Patrick G Northup; Carl L Berg
Journal:  Ann Hepatol       Date:  2009 Oct-Dec       Impact factor: 2.400

6.  Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.

Authors:  Heather M Patton; Joel E Lavine; Mark L Van Natta; Jeffrey B Schwimmer; David Kleiner; Jean Molleston
Journal:  Gastroenterology       Date:  2008-09-03       Impact factor: 22.682

7.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

Authors:  Michelle M Richardson; Julie R Jonsson; Elizabeth E Powell; Elizabeth M Brunt; Brent A Neuschwander-Tetri; Prithi S Bhathal; John B Dixon; Martin D Weltman; Herbert Tilg; Alexander R Moschen; David M Purdie; Anthony J Demetris; Andrew D Clouston
Journal:  Gastroenterology       Date:  2007-05-16       Impact factor: 22.682

8.  Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.

Authors:  Elizabeth M Brunt; Sunil Ramrakhiani; Barry G Cordes; Brent A Neuschwander-Tetri; Christine G Janney; Bruce R Bacon; Adrian M Di Bisceglie
Journal:  Mod Pathol       Date:  2003-01       Impact factor: 7.842

9.  Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.

Authors:  Carolin Lackner; Margit Gogg-Kamerer; Kurt Zatloukal; Conny Stumptner; Elizabeth M Brunt; Helmut Denk
Journal:  J Hepatol       Date:  2008-02-22       Impact factor: 25.083

10.  Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.

Authors:  Hideki Fujii; Yoshihiro Ikura; Junko Arimoto; Kenichi Sugioka; Julia C Iezzoni; Sang Hoon Park; Takahiko Naruko; Hiroyuki Itabe; Norifumi Kawada; Stephen H Caldwell; Makiko Ueda
Journal:  J Atheroscler Thromb       Date:  2009-12-22       Impact factor: 4.928
View more
  3 in total

1.  Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223.

Authors:  Carolina Jimenez Calvente; Masahiko Tameda; Casey D Johnson; Hana Del Pilar; Yun Chin Lin; Nektaria Adronikou; Xavier De Mollerat Du Jeu; Cristina Llorente; Josh Boyer; Ariel E Feldstein
Journal:  J Clin Invest       Date:  2019-07-11       Impact factor: 14.808

Review 2.  From the origin of NASH to the future of metabolic fatty liver disease.

Authors:  Andreas Geier; Dina Tiniakos; Helmut Denk; Michael Trauner
Journal:  Gut       Date:  2021-02-25       Impact factor: 23.059

Review 3.  Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics.

Authors:  Arshi Khanam; Shyam Kottilil
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.